A REVIEW ON: COMMELINA BENGHALESIS AN EFFECTIVE MANAGEMENT OF DIABETICS

Abstract

A chronic metabolic disease called diabetes mellitus is characterized by persistently high blood sugar levels brought on by either decreased insulin action or secretion, or both. Particularly, the rising incidence of type 2 diabetes has spurred a great deal of study into complementary and alternative medicine. A wild herb that has long been employed in a variety of folk medicines, Commelina benghalensis (dayflower) has drawn interest among medicinal plants due to its possible antidiabetic effects. Packed with phytochemicals, including phenolic compounds, alkaloids, flavonoids, tannins, and saponins, C. benghalensis has a variety of pharmacological benefits, such as anti-inflammatory, hypoglycemic, and antioxidant properties. It has been shown in experiments to protect pancreatic β-cells in diabetes animals, increase insulin sensitivity, and regulate blood glucose levels. The purpose of this review is to gather the most recent information on Commelina benghalensis's phytoconstituents, antidiabetic action mechanisms, pharmacological investigations, dose forms, and therapeutic efficacy. The safety profile, standardisation issues, and potential for clinical translation in the future are also highlighted. C. benghalensis may be a viable natural alternative for managing diabetes, either on its alone or in conjunction with current treatments, according to its traditional use and promising pharmacological profile.